AKT1 and cervical carcinoma: Similarly, in cervical cancer, RBM15 inhibition reduces m6A methylation of OTUB2, leading to the inactivation of the AKT/mTOR pathway, which in turn decreases cell proliferation and metastasis capacity (Song and Wu 2023).